Profilo
Michael Listgarten is General Counsel at ALX Oncology Holdings, Inc. since 2026.
Formerly, General Counsel at Rapt Therapeutics, Inc. from 2023 to 2026, Vice President-Healthcare Law at Principia Biopharma, Inc. in 2020, and VP-Healthcare Law & Chief Compliance Officer at Adamas Pharmaceuticals LLC in 2021.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Pennsylvania.
Posizioni attive di Michael Listgarten
| Società | Posizione | Inizio |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Consigliere Generale | 30/06/2026 |
Precedenti posizioni note di Michael Listgarten
| Società | Posizione | Fine |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Consigliere Generale | 03/03/2026 |
| ADAMAS PHARMACEUTICALS, INC. | Responsabile della Conformità | 01/11/2021 |
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | 01/12/2020 |
Formazione di Michael Listgarten
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
ALX Oncology Holdings, Inc.
ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
















